Unnamed: 0,title,date,stock,sentiment
628102.0,"UBS Maintains Buy on Hill-Rom Holdings, Lowers Price Target to $125",2020-05-04 10:33:00-04:00,HRC,negative
628103.0,Hill-Rom Holdings: Q2 Earnings Insights,2020-05-01 07:51:00-04:00,HRC,neutral
628104.0,"Hill-Rom Holdings Q2 Adj. EPS $1.280 Beats $1.150 Estimate, Sales $723.000M Beat $701.640M Estimate",2020-05-01 06:58:00-04:00,HRC,neutral
628105.0,Stocks That Hit 52-Week Highs On Tuesday,2020-04-28 10:18:00-04:00,HRC,neutral
628106.0,"Companies Cited In Trump Memo Are General Electric, Hill-Rom Holdings, Medtronic, Resmed, Royal Philips And Vyaire Medical",2020-04-02 15:39:00-04:00,HRC,neutral
628107.0,"Morgan Stanley Maintains Overweight on Hill-Rom Holdings, Lowers Price Target to $125",2020-03-27 09:37:00-04:00,HRC,negative
628108.0,Hillrom Reports Business Operations Continue With No Material Interruption As Global Demand For Several Critical Products Has Grown Substantially,2020-03-24 16:07:00-04:00,HRC,negative
628109.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,HRC,negative
628110.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,HRC,negative
628111.0,"Barclays Upgrades Hill-Rom Holdings to Overweight, Announces $116 Price Target",2020-03-17 05:21:00-04:00,HRC,negative
628112.0,Hill-Rom Sees Q2 Adj. EPS $1.14-$1.16 vs $1.24 Estimate; FY20 Adj. EPS $5.50-$5.56 vs $5.52 Est.,2020-01-24 07:00:00-05:00,HRC,neutral
628113.0,"Hill-Rom Holdings Q1 Adj. EPS $1.13 Beats $1.08 Estimate, Sales $685M Beat $684.01M Estimate",2020-01-24 06:59:00-05:00,HRC,neutral
628114.0,"Earnings Scheduled For January 24, 2020",2020-01-24 04:27:00-05:00,HRC,neutral
628115.0,Stocks That Hit 52-Week Highs On Friday,2020-01-10 12:18:00-05:00,HRC,neutral
628116.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,HRC,neutral
628117.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,HRC,neutral
628118.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-17 11:19:00-05:00,HRC,neutral
628119.0,"Benzinga's Top Upgrades, Downgrades For December 17, 2019",2019-12-17 11:16:00-05:00,HRC,positive
628120.0,"Morgan Stanley Upgrades Hill-Rom Holdings to Overweight, Announces $138 Price Target",2019-12-17 06:33:00-05:00,HRC,negative
628121.0,Hillrom Adds $170M To Buyback,2019-11-08 07:00:00-05:00,HRC,neutral
628122.0,"Morgan Stanley Maintains Equal-Weight on Hill-Rom Holdings, Raises Price Target to $113",2019-11-04 09:05:00-05:00,HRC,neutral
628123.0,"UBS Maintains Buy on Hill-Rom Holdings, Raises Price Target to $130",2019-11-04 07:36:00-05:00,HRC,neutral
628124.0,Stocks That Hit 52-Week Highs On Friday,2019-11-01 10:31:00-04:00,HRC,neutral
628125.0,"Hill-Rom Sees FY20 Adj. EPS $5.46-$5.56 vs $5.47 Estimate, Core Sales Growth 5-6%",2019-11-01 06:37:00-04:00,HRC,positive
628126.0,"Hill-Rom Holdings Q4 Adj. EPS $1.69 Beats $1.65 Estimate, Sales $782.8M Beat $760.14M Estimate",2019-11-01 06:36:00-04:00,HRC,neutral
628127.0,"Spruce Point Capital Issues 'Strong Sell' Opinion On Hill-Rom, Sees 25%-55% Downside Risk",2019-10-29 09:39:00-04:00,HRC,positive
628128.0,Hill-Rom Reports Launch Of $425M Private Placement,2019-09-05 07:42:00-04:00,HRC,neutral
628129.0,10 Biggest Price Target Changes For Tuesday,2019-08-06 08:53:00-04:00,HRC,neutral
628130.0,"Barclays Maintains Equal-Weight on Hill-Rom Holdings, Raises Price Target to $116",2019-08-06 07:46:00-04:00,HRC,neutral
628131.0,"KeyBanc Maintains Overweight on Hill-Rom Holdings, Raises Price Target to $125",2019-08-05 08:14:00-04:00,HRC,negative
628132.0,Hillrom Buys Breathe Technologies In $130M Deal,2019-08-02 10:14:00-04:00,HRC,neutral
628133.0,Hillrom Reports Purchase Of Breathe Technologies For $130M,2019-08-02 06:59:00-04:00,HRC,neutral
628134.0,Hillrom Sees Q4 Adj. EPS $1.64-$1.66 vs $1.67 Estimate; FY19 Adj. EPS $5.03-$5.05 vs $5.04 Est.,2019-08-02 06:59:00-04:00,HRC,neutral
628135.0,"Hillrom Holdings Q3 EPS $1.23 Beats $1.22 Estimate, Sales $726.8M Beat $718.2M Estimate",2019-08-02 06:58:00-04:00,HRC,neutral
628136.0,"Earnings Scheduled For August 2, 2019",2019-08-02 04:01:00-04:00,HRC,neutral
628137.0,Hill-Rom Holdings Earnings Preview,2019-08-01 14:17:00-04:00,HRC,neutral
628138.0,Hillrom Announces Audax Private Equity Has Entered Into A Definitive Agreement To Acquire Aspen Surgical; Financial Details Not Disclosed,2019-07-10 11:08:00-04:00,HRC,positive
628139.0,Hillrom To Sell Certain Surgical Consumable Products And Related Assets For $170M In Cash,2019-07-10 08:03:00-04:00,HRC,positive
628140.0,"Hill-Rom Holdings Sees Q3 Adj. EPS $1.20-$1.22 vs $1.24 Est., Sees FY19 Adj. EPS $5.02-$5.06 vs $5.04 Est.",2019-04-26 06:36:00-04:00,HRC,neutral
628141.0,"Hill-Rom Holdings Q2 Adj. EPS $1.14 Beats $1.11 Estimate, Sales $714M Beat $706.38M Estimate",2019-04-26 06:35:00-04:00,HRC,neutral
628142.0,"Earnings Scheduled For April 26, 2019",2019-04-26 04:02:00-04:00,HRC,neutral
628143.0,A Peek Into The Markets: Boeing Leads Dow Futures Lower,2019-03-11 07:17:00-04:00,HRC,negative
628144.0,Hill-Rom to Acquire Voalte for $180M Cash,2019-03-11 06:58:00-04:00,HRC,neutral
628145.0,Hill-Rom Raises Quarterly Dividend From $0.20 To $0.21/Share,2019-03-06 17:04:00-05:00,HRC,neutral
628146.0,55 Biggest Movers From Friday,2019-01-28 05:40:00-05:00,HRC,neutral
628147.0,35 Stocks Moving In Friday's Mid-Day Session,2019-01-25 12:32:00-05:00,HRC,neutral
628148.0,Hill-Rom Holdings shares are trading higher after the company beat Q1 EPS and sales estimates.,2019-01-25 10:55:00-05:00,HRC,positive
628149.0,"Hill-Rom Reaffirms FY19 Sales Growth, Adj. EPS Guidance",2019-01-25 06:59:00-05:00,HRC,positive
628150.0,"Hill-Rom Holdings Q1 EPS $1.02 Beats $0.99 Estimate, Sales $683.5M Beat $676.38M Estimate",2019-01-25 06:59:00-05:00,HRC,neutral
628151.0,"Earnings Scheduled For January 25, 2019",2019-01-25 04:07:00-05:00,HRC,neutral
628152.0,Hill-Rom Announces Collaboration With Microsoft,2019-01-08 06:55:00-05:00,HRC,neutral
628153.0,"Stocks That Will Be Trading Ex Dividend Thurs., Dec. 13, 2018",2018-12-12 11:15:00-05:00,HRC,neutral
628154.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018",2018-12-04 09:20:00-05:00,HRC,neutral
628155.0,"UBS Initiates Coverage On Hill-Rom Holdings with Buy Rating, Announces $115 Price Target",2018-11-28 08:02:00-05:00,HRC,neutral
628156.0,"Raymond James Maintains Outperform on Hill-Rom Holdings, Raises Price Target to $105",2018-11-05 11:47:00-05:00,HRC,neutral
628157.0,"Hill-Rom Holdings Inc Q4 EPS $1.63 Beats $1.51 Estimate, Sales $759.2M Beat $750.9M Estimate",2018-11-02 06:56:00-04:00,HRC,neutral
628158.0,"Earnings Scheduled For November 2, 2018",2018-11-02 06:12:00-04:00,HRC,neutral
628159.0,"Barclays Initiates Coverage On Hill-Rom Holdings with Equal-Weight Rating, Announces $95 Price Target",2018-10-16 07:11:00-04:00,HRC,neutral
628160.0,"Stocks Trading Ex Dividend For Thurs., Sep. 20, 2018",2018-09-20 06:25:00-04:00,HRC,neutral
628161.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,HRC,neutral
628162.0,"Stocks Which Set New 52-Week High Yesterday, August 23rd",2018-08-24 09:11:00-04:00,HRC,neutral
628163.0,"Stocks Which Set New 52-Week High Yesterday, August 22nd",2018-08-23 10:51:00-04:00,HRC,neutral
628164.0,"Stocks Which Set New 52-Week High Yesterday, August 21st",2018-08-22 09:06:00-04:00,HRC,neutral
628165.0,"Stocks Which Set New 52-Week High Tues., Aug. 21, 2018",2018-08-21 14:50:00-04:00,HRC,neutral
628166.0,"Stocks Which Set New 52-Week High Yesterday, August 9th",2018-08-10 10:03:00-04:00,HRC,neutral
628167.0,"Raymond James Maintains Outperform on Hill-Rom Holdings, Raises Price Target to $100",2018-07-30 09:29:00-04:00,HRC,neutral
628168.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,HRC,neutral
628169.0,Hill-Rom Sees Q4 Adj. EPS $1.50-$1.53,2018-07-27 06:33:00-04:00,HRC,neutral
628170.0,Hill-Rom Narrows FY18 Adj. EPS Outlook From $4.60-$4.65 To $4.62-$4.64 vs $4.62 Estimate,2018-07-27 06:33:00-04:00,HRC,neutral
628171.0,"Hill-Rom Holdings Q3 EPS $1.15 Beats $1.13 Estimate, Sales $708.6M Beat $707.5M Estimate",2018-07-27 06:32:00-04:00,HRC,neutral
628172.0,"Earnings Scheduled For July 27, 2018",2018-07-27 04:11:00-04:00,HRC,neutral
628173.0,"Stocks Which Set New 52-Week High Yesterday, July 24th:",2018-07-25 12:14:00-04:00,HRC,neutral
628174.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,HRC,neutral
628175.0,Hill-Rom Changes Q3 Earnings Conf. Call Time to Friday July 27th 8am ET,2018-07-19 16:22:00-04:00,HRC,neutral
628176.0,10 Biggest Price Target Changes For Tuesday,2018-07-17 09:35:00-04:00,HRC,neutral
628177.0,"KeyBanc Maintains Overweight on Hill-Rom Holdings, Raises Price Target to $115",2018-07-17 06:21:00-04:00,HRC,negative
628178.0,"Hill-Rom Names John Groetelaars Pres, CEO",2018-04-27 06:58:00-04:00,HRC,neutral
628179.0,"Hill-Rom Sees Q3 Adj. EPS $1.12-$1.14 vs $1.16 Est., Core Sales Growth Up ~3-4%",2018-04-27 06:58:00-04:00,HRC,positive
628180.0,Hill-Rom Narrows FY18 Adj. EPS Outlook From $4.57-$4.65 To $4.60-$4.65 vs $4.61 Est.,2018-04-27 06:57:00-04:00,HRC,neutral
628181.0,"Hill-Rom Q2 Adj. EPS $1.05 Beats $1.02 Est., Sales $711M Beats $705.5M Est.",2018-04-27 06:56:00-04:00,HRC,neutral
628182.0,"Earnings Scheduled For April 27, 2018",2018-04-27 04:36:00-04:00,HRC,neutral
628183.0,Earnings Outlook For Hill-Rom Holdings,2018-04-26 14:28:00-04:00,HRC,neutral
628184.0,"Goldman Sachs Initiates Coverage On Hill-Rom Holdings with Neutral Rating, Announces $85.00 Price Target",2018-04-04 08:36:00-04:00,HRC,neutral
628185.0,"Hill-Rom Announces Divestiture Of Third-Party Rental Business, Expects After Tax Charges of $20M",2018-03-12 06:56:00-04:00,HRC,negative
628186.0,Hill-Rom Raises Qtr Dividend From $0.18 to $0.20/Share,2018-03-07 06:55:00-05:00,HRC,neutral
628187.0,Hill-Rom Reports CEO John Greisch To Retire,2018-01-26 06:53:00-05:00,HRC,neutral
628188.0,Hill-Rom Raises FY20 Adj. EPS Guidance From Up 10-12% To Up 12-14% CAGR,2018-01-26 06:52:00-05:00,HRC,neutral
628189.0,Hill-Rom Sees Q2 Adj. EPS $1-$1.02 vs $1.02 Est.,2018-01-26 06:51:00-05:00,HRC,neutral
628190.0,UPDATE: Hill-Rom Raises FY18 Adj. EPS Outlook To $4.57-$4.65 vs $4.42 Est.,2018-01-26 06:51:00-05:00,HRC,neutral
628191.0,Hill-Rom Raises FY18 Outlook,2018-01-26 06:51:00-05:00,HRC,neutral
628192.0,"Hill-Rom Reports Q1 Adj. EPS $0.92 vs $0.81 Est., Sales $670M vs $663.7M Est.",2018-01-26 06:50:00-05:00,HRC,neutral
628193.0,"Earnings Scheduled For January 26, 2018",2018-01-26 04:18:00-05:00,HRC,neutral
628194.0,The 10 Most Expensive Stocks In The S&P 500,2018-01-23 13:23:00-05:00,HRC,neutral
628195.0,Hill Rom Reports RetinaVue Received Joint Commission Accreditation,2018-01-17 07:14:00-05:00,HRC,neutral
628196.0,Hill-Rom Sees Incurring 1-Time Net Benefit Of ~$50M-$75M Primarily In Q1,2018-01-09 08:01:00-05:00,HRC,positive
628197.0,Hill-Rom Sees Q1 Sales ~$670M vs $656.5M Est.,2018-01-09 08:00:00-05:00,HRC,neutral
628198.0,Hill-Rom Sees Q1 Adj. EPS Exceeding Previously Issued Range Of $0.77-$0.79,2018-01-09 08:00:00-05:00,HRC,neutral
628199.0,Raymond James Upgrades Hill-Rom Holdings to Outperform,2018-01-03 07:42:00-05:00,HRC,neutral
628200.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2018",2018-01-02 09:29:00-05:00,HRC,positive
628201.0,Morgan Stanley Downgrades Hill-Rom Holdings to Equal-Weight,2018-01-02 07:20:00-05:00,HRC,neutral
628202.0,"IMRIS, Hill-Rom Report FDA Cleared New MRI-Condtional Surgical Table For Hybrid OR",2017-11-27 10:02:00-05:00,HRC,positive
628203.0,Hill-Rom Gives a 2020 Outlook,2017-11-03 06:50:00-04:00,HRC,neutral
628204.0,Hill-Rom Q4 Adj. EPS $1.18 vs $1.28 Est.,2017-11-03 06:49:00-04:00,HRC,neutral
628205.0,Hill-Rom Sees Q1 EPS $0.77 to $0.79 vs $0.89 Est.,2017-11-03 06:48:00-04:00,HRC,neutral
628207.0,"Hill-Rom Q4 EPS $1.03 vs $1.28 Est., Sales $738.3M vs $731.1M Est.",2017-11-03 06:46:00-04:00,HRC,neutral
628208.0,"Earnings Scheduled For November 3, 2017",2017-11-03 04:11:00-04:00,HRC,neutral
628209.0,Hill-Rom Says its Puerto Rico Manufacturing Facility Sustained Minor Structural Damage from Hurricane Maria,2017-10-11 07:00:00-04:00,HRC,negative
628210.0,Hill-Rom Sees Q4 Adj. EPS $1.26-$1.30 vs $1.33 Est.; Sees FY17 Adj. EPS $3.80-$3.84 vs $3.86 Est.,2017-07-28 07:00:00-04:00,HRC,neutral
628211.0,"Hill-Rom Reports Q3 Adj. EPS $0.91, Inline, Sales $689M vs $693.8M Est.",2017-07-28 06:59:00-04:00,HRC,neutral
628212.0,"Needham Initiates Coverage On Hill-Rom Holdings with Buy Rating, Announces $95.00 Price Target",2017-06-30 06:59:00-04:00,HRC,neutral
628213.0,"Cantor Fitzgerald Initiates Coverage On Hill-Rom Holdings with Neutral Rating, Announces $86.00 Price Target",2017-06-30 06:26:00-04:00,HRC,neutral
628214.0,"Hill-Rom Announces Entry Into Agreement to Divest Völker Business, Terms Not Disclosed",2017-06-27 07:30:00-04:00,HRC,positive
628219.0,Hill-Rom Sees Q3 Adj. EPS $0.89-$0.91 vs $0.97 Est.,2017-04-28 07:13:00-04:00,HRC,neutral
628220.0,UPDATE: Hill-Rom Raises FY17 Adj. EPS Outlook from $3.74-$3.82 to $3.82-$3.88 vs $3.82 Est.,2017-04-28 07:12:00-04:00,HRC,neutral
628221.0,Hill-Rom Raises FY17 Outlook,2017-04-28 07:12:00-04:00,HRC,neutral
628222.0,"Hill-Rom Reports Q2 Adj. EPS $0.88 vs $0.79 Est., Sales $679M vs $655M ESt.",2017-04-28 07:00:00-04:00,HRC,neutral
628223.0,Hill-Rom Raises Qtr. Dividend from $0.17 to $0.18/Share,2017-03-14 16:02:00-04:00,HRC,neutral
628224.0,"Barclays Initiates Coverage On Hill-Rom Holdings At Overweight, Announces $70 Price Target",2017-02-08 06:19:00-05:00,HRC,negative
628225.0,"Hill-Rom Sees Q2 EPS 0.77-$0.79 vs. Est. $0.80, Rev. Increase Of 2-3%; Sees FY17 Rev. To Increase ~1%, EPS $3.74-$3.82 vs. Est. $3.79",2017-01-27 07:01:00-05:00,HRC,positive
628226.0,"Hill-Rom Reports Q1 EPS $0.75 vs. Est. $0.76, Rev. $637M vs. Est. $654M",2017-01-27 06:59:00-05:00,HRC,neutral
628227.0,"Earnings Scheduled For January 27, 2017",2017-01-27 04:36:00-05:00,HRC,neutral
628228.0,"Benzinga's Top Upgrades, Downgrades For January 24, 2017",2017-01-24 09:23:00-05:00,HRC,positive
628229.0,Stifel Nicolaus Initiates Coverage On Hill-Rom Holdings at Buy,2017-01-24 06:07:00-05:00,HRC,neutral
628230.0,"Hill-Rom to Acquire Mortara Instrument for $330M Cash, Says Tax Benefit to Lower Present Value by $40M",2017-01-10 08:06:00-05:00,HRC,positive
628231.0,Hill-Rom Holdings Sees FY2017 EPS $3.74-3.82 vs $3.78 Est; Reaffirms Outlook,2017-01-10 08:05:00-05:00,HRC,neutral
628232.0,Hill-Rom Holdings Narrows Q1 EPS Guidance from $0.75-0.77 to $0.75-0.76 vs $0.76 Est,2017-01-10 08:04:00-05:00,HRC,neutral
628233.0,Morgan Stanley Lists Top SMID Stocks To Buy And Sell Headed Into 2017,2016-12-27 16:07:00-05:00,HRC,positive
628234.0,Hill-Rom Sees Q1 Adj. EPS $0.75-$0.77 vs $0.87 Est.; FY17 Adj. EPS $3.74-$3.82 vs $3.77 Est.,2016-11-03 07:19:00-04:00,HRC,neutral
628235.0,"Hill-Rom Reports Q4 Adj. EPS $1.18 vs $1.13 Est., Sales $706M vs $701.4M Est.",2016-11-03 07:18:00-04:00,HRC,neutral
628236.0,Thursday Morning's Top Earnings Reports,2016-08-04 09:56:00-04:00,HRC,positive
628237.0,"UPDATE: Hill-Rom Raises FY16 Adj. EPS Outlook from $3.26-$3.30 to $3.32-$3.34 vs $3.27 Est., Sales from $2.64B-$2.67B to ~$2.65B vs $2.65B Est.",2016-08-04 06:06:00-04:00,HRC,neutral
628238.0,"Hill-Rom Reports Q3 Adj. EPS $0.81 vs $0.76 Est., Sales $655M vs $646.6M Est.; Raises FY Outlook",2016-08-04 06:05:00-04:00,HRC,neutral
628239.0,BMO Capital Highlights This Week's MedTech Earnings,2016-08-01 15:14:00-04:00,HRC,neutral
628240.0,Here Are The 14 Stocks Morgan Stanley Wants You To Focus On During Q2 Earnings,2016-07-19 08:30:00-04:00,HRC,neutral
628241.0,"Hill-Rom Story Not Appreciated By Wall Street, Says Morgan Stanley",2016-06-16 10:02:00-04:00,HRC,negative
628242.0,8 Largest Price Target Changes For Thursday,2016-06-16 09:31:00-04:00,HRC,neutral
628243.0,Benzinga's Top Upgrades,2016-06-16 08:57:00-04:00,HRC,positive
628244.0,"Morgan Stanley Upgrades Hill-Rom Holdings to Overweight, Raises PT to $62.00",2016-06-16 07:47:00-04:00,HRC,negative
628245.0,"Hill-Rom, Haldor Advanced Technologies Enter Global Distribution Partnership",2016-05-11 04:12:00-04:00,HRC,positive
628246.0,Hill-Rom Sees Q3 Adj. EPS $0.75-$0.77 vs $0.82 Est.,2016-04-29 06:05:00-04:00,HRC,neutral
628247.0,"UPDATE: Hill-Rom Cuts FY16 Sales Outlook from $2.66B-$2.7B to $2.64B-$2.67B vs $2.68B Est., Adj. EPS from $3.24-$3.30 to $3.26-$3.30 vs $3.28 Est.",2016-04-29 06:04:00-04:00,HRC,negative
628248.0,"Hill-Rom Cuts FY16 Sales Outlook, Narrows EPS Guidance",2016-04-29 06:04:00-04:00,HRC,negative
628249.0,"Hill-Rom Reports Q2 Adj. EPS $0.71 vs $0.70 Est., Sales $632.6M vs $651.8M Est.",2016-04-29 06:03:00-04:00,HRC,neutral
628250.0,"Earnings Scheduled For April 29, 2016",2016-04-29 04:07:00-04:00,HRC,neutral
628251.0,"Hill-Rom Holdings Raises Qrt DIvidend From $0.16 To $0.17, Annualize Increases From $0.64 To $0.68",2016-02-26 08:04:00-05:00,HRC,neutral
628252.0,Earnings Recap For February 1,2016-02-01 16:35:00-05:00,HRC,neutral
628253.0,"Hill-Rom Sees Q2 EPS $0.68 to $0.70 vs $0.77 est, Revenue $645M to $655M vs $661M est",2016-02-01 06:06:00-05:00,HRC,neutral
628254.0,"Hill-Rom Sees FY 2016 EPS $3.24 to $3.30 vs $3.20 est, Revenue $2.66B vs $2.7B vs $2.96B est",2016-02-01 06:04:00-05:00,HRC,neutral
628255.0,"Hill-Rom Holdings Q1 EPS $0.68 vs $0.65 est, Revenue $661M vs $660M est",2016-02-01 06:01:00-05:00,HRC,neutral
628256.0,"Earnings Scheduled For February 1, 2016",2016-02-01 04:01:00-05:00,HRC,neutral
628257.0,"Intuitive Surgical, Hill-Rom Report Clearance for Integrated Table Motion",2016-01-21 16:16:00-05:00,HRC,neutral
628258.0,Benzinga's Top Upgrades,2016-01-21 08:50:00-05:00,HRC,positive
628259.0,KeyBanc Upgrades Hill-Rom Holdings to Overweight,2016-01-21 06:18:00-05:00,HRC,negative
628260.0,Hill-Rom Reports Q1 Prelim. Rev. ~$661M vs. Est. $660.82M,2016-01-12 08:02:00-05:00,HRC,neutral
628261.0,Hill-Rom Holdings Reports Q4 EPS $0.89 Vs est $0.80,2015-11-05 06:01:00-05:00,HRC,neutral
628262.0,Hill-Rom Holdings Sees Q4 EPS $0.80-$0.82 vs Est $0.78 & Revs $545M-$555M Vs Ewst $489.85M; Sees FY 2015 EPS $2.55-$2.57 vs Est $2.53 & Revs $1.96B-$1.97B Vs Est $1.90B,2015-09-25 09:07:00-04:00,HRC,neutral
628263.0,"Hil-Rom Holdings Reports Q2 EPS $0.62 Vs Est $0.61, Sales $474.5M Vs Est $447.54M, Q2 Adj EPS $0.76-$0.79 Vs Est $0.78; Sees FY Adj EPS $2.51-$2.54 Vs Est $2.52 & Revs up 12%-13%",2015-08-07 06:03:00-04:00,HRC,neutral
628264.0,"Hill-Rom Q3 EPS $0.62 vs $0.61 est, Revenue $475M vs $448M est",2015-08-07 06:01:00-04:00,HRC,neutral
628265.0,Hill-Rom's Proposed Acquisition Of Welch Allyn Receives Antitrust Clearance,2015-07-14 08:31:00-04:00,HRC,neutral
628266.0,Benzinga's Volume Movers,2015-06-18 10:21:00-04:00,HRC,neutral
628267.0,"Benzinga's M&A Chatter for Wednesday June 17, 2015",2015-06-17 18:17:00-04:00,HRC,neutral
628268.0,Mid-Afternoon Market Update: DavidsTea Falls After Q1 Results; Synergy Pharmaceuticals Shares Spike Higher,2015-06-17 14:55:00-04:00,HRC,positive
628269.0,Mid-Day Market Update: Kythera Biopharmaceuticals Jumps On Acquisition News; La-Z-Boy Shares Slide,2015-06-17 13:03:00-04:00,HRC,positive
628270.0,Mid-Morning Market Update: Markets Rise; Allergan To Acquire Kythera Biopharmaceuticals For $2.1B,2015-06-17 10:30:00-04:00,HRC,neutral
628271.0,Benzinga's Volume Movers,2015-06-17 10:20:00-04:00,HRC,neutral
628272.0,Stocks Hitting 52-Week Highs,2015-06-17 10:06:00-04:00,HRC,neutral
628273.0,Morning Market Gainers,2015-06-17 09:42:00-04:00,HRC,neutral
628274.0,UPDATE: Welch Allyn Shareholders Will Receive 1.625B Cash And 8.1M Shares Of Newly Issued Hill-Rom Stock,2015-06-17 07:02:00-04:00,HRC,positive
628275.0,"Hill-Rom Acquires Welch Allyn For $2.05B In Cash, Stock",2015-06-17 07:01:00-04:00,HRC,neutral
628276.0,"Hill Rom Expects FY EPS $2.50 to $2.54, Previous $2.44 to $2.50, Est $2.48",2015-05-05 06:11:00-04:00,HRC,neutral
628277.0,"Hill Rom Q2 EPS $0.64 vs $0.60 est, Revenue $475M vs $472M est",2015-05-05 06:01:00-04:00,HRC,neutral
628278.0,Bank of America Upgrades Hill-Rom Holdings to Buy,2015-04-06 08:12:00-04:00,HRC,neutral
628279.0,Hill-Rom Raises Qtr. Dividend from $0.1525 to $0.16/Share,2015-03-04 09:02:00-05:00,HRC,neutral
628280.0,"Hill-Rom Holdings Reports In-Line Q1 Adj. EPS $0.49, Revs $465M; Sees Q2 Adj. EPS $0.57-$0.60; Sees FY2015 EPS $2.44-$2.55, Saw $2.42-$2.48",2015-02-03 06:06:00-05:00,HRC,neutral
628281.0,Fast Money Halftime Report Final Trade From January 15,2015-01-15 16:20:00-05:00,HRC,neutral
628282.0,Hill-Rom Holdings Reports Prelim. Q1 Sales $465.0M vs $453.60M Est,2015-01-14 16:05:00-05:00,HRC,neutral
628283.0,Shares of Hill-Rom Holdings Up ~3% Following Bank of America Upgrade to Neutral,2015-01-07 10:19:00-05:00,HRC,positive
628284.0,"Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades",2015-01-05 15:57:00-05:00,HRC,neutral
628285.0,Morgan Stanley Upgrades Hill-Rom Holdings to Equalweight,2015-01-05 08:52:00-05:00,HRC,neutral
628286.0,"Goldman Sachs Upgrades Hill-Rom Holdings Inc to Conviction Buy, Maintains $53.00 PT",2014-12-02 05:59:00-05:00,HRC,neutral
628287.0,"Hill-Rom And Stryker Added To Goldman's ""Conviction Buy List""",2014-12-02 05:58:00-05:00,HRC,neutral
628288.0,Hill-Rom Holdings Inc Reports Q4 EPS of $0.74 vs $0.71 Est; Revenue of $480.0M vs $467.50M Est,2014-11-05 06:01:00-05:00,HRC,neutral
628289.0,Hill-Rom Appoints Steven J. Strobel CFO,2014-10-27 08:32:00-04:00,HRC,neutral
628290.0,"Option Alert: Hill-Rom Dec $45 Call; 1,400 Contract Trade at Ask @$1.55; Currently $43.64",2014-10-23 14:52:00-04:00,HRC,positive
628291.0,Hill-Rom Appoints Carlyn Solomon New COO,2014-10-09 17:00:00-04:00,HRC,neutral
628292.0,Hill-Rom Announces 7 Year Contract With Providence Health,2014-09-23 11:31:00-04:00,HRC,neutral
628293.0,"Hill-Rom, GE Report Settlement Related to Patent Infringement Suit, Agrees to License Hadn Hygiene Patents to GE",2014-08-25 10:00:00-04:00,HRC,negative
628294.0,"Hill-Rom Holdings Reports Q2 Adjusted EPS of $0.59, Inline; Revenue of $398.0M vs $411.41M Est",2014-08-07 06:18:00-04:00,HRC,neutral
628295.0,8-K from Hill-rom Shows CFO Jay Saccaro Will Resign,2014-07-07 09:01:00-04:00,HRC,negative
628296.0,Morgan Stanley Sees End-Market Pressure On Hill-Rom,2014-06-17 08:36:00-04:00,HRC,negative
628297.0,US Stock Futures Decline Ahead Of Economic Data,2014-06-16 07:32:00-04:00,HRC,neutral
628298.0,Hill-Rom to Acquire TRUMPF Medical for Approximately $250M in Cash,2014-06-16 06:01:00-04:00,HRC,neutral
628299.0,UPDATE: Morgan Stanley Reiterates On Hill-Rom Holdings As End-Market Pressure Remains,2014-05-02 10:01:00-04:00,HRC,negative
628300.0,Hill-Rom Holdings Reports Q2 Adjusted EPS of $0.57 vs $0.51 Est; Revenue of $415.0M vs $412.02M Est,2014-05-02 06:04:00-04:00,HRC,neutral
628301.0,Northcoast Research Downgrades Hill-Rom Holdings Inc to Neutral,2014-04-11 09:34:00-04:00,HRC,neutral
628302.0,Hill-Rom Elects William G. Dempsey to its Board of Directors,2014-03-10 08:05:00-04:00,HRC,neutral
628303.0,Hill-Rom Announces 11% Dividend Increase in Second Quarter 2014,2014-03-07 08:03:00-05:00,HRC,positive
628304.0,Morning Market Losers ,2014-01-23 10:02:00-05:00,HRC,negative
628305.0,Hill-Rom Reports Q1 EPS of $0.22 vs $0.51 Est; Revenue of $393.40M vs $406.04M Est,2014-01-23 05:46:00-05:00,HRC,neutral
628306.0,Hill-Rom Names James Saccaro CFO,2013-12-02 09:00:00-05:00,HRC,neutral
628307.0,Morgan Stanley Downgrades Hill-Rom Holdings Inc to Underweight,2013-11-11 07:38:00-05:00,HRC,neutral
628308.0,Wells Fargo Downgrades Hill-Rom Holdings Inc to Market Perform,2013-10-25 07:22:00-04:00,HRC,positive
628309.0,Hill-Rom Holdings Inc Sees Q1 EPS $0.50-0.52 vs $0.51 Est,2013-10-23 17:04:00-04:00,HRC,neutral
628310.0,Hill-Rom Holdings Inc Reports Q4 EPS of $0.65 vs $0.60 Est,2013-10-23 17:00:00-04:00,HRC,neutral
628311.0,"Hill-Rom Adds $150M to Buyback Plan, Now Totals $190M",2013-09-10 09:01:00-04:00,HRC,neutral
628312.0,Hill-Rom Sees Q4 EPS $0.59-0.61; Sees Sales $435.0M-440.0M,2013-07-24 17:33:00-04:00,HRC,neutral
628313.0,"CORRECTION: Hill-Rom Holdings Inc Reports Q3 EPS of $0.49, Inline; Revenue of $424.20M vs $424.40M Est",2013-07-24 17:31:00-04:00,HRC,neutral
628314.0,Hill-Rom Holdings Inc Reports Q3 EPS of $0.39 vs $0.49 Est; Revenue of $424.20M vs $424.40M Est,2013-07-24 17:31:00-04:00,HRC,neutral
628315.0,Quest Diagnostics Names Mark J. Guinan as New CFO ,2013-07-17 17:00:00-04:00,HRC,neutral
628316.0,Hill-Rom Holdings Inc Sees Q3 EPS $0.49 vs $0.50 Est; Sees Sales $424.0M vs $425.80M Est,2013-07-17 16:01:00-04:00,HRC,neutral
628317.0,Hill-Rom Announces Preliminary Fiscal 2013 Third Quarter Results and Search for New CFO; Adjusted Earnings Per Share Expected to be in Line with Guidance ,2013-07-17 16:00:00-04:00,HRC,positive
628318.0,UPDATE: Goldman Sachs Downgrades Hill-Rom Holdings on Outperformance,2013-07-09 09:15:00-04:00,HRC,neutral
628319.0,"CL King Upgrades Hill-Rom Holdings Inc to Neutral, Maintains $28.00 PT",2013-05-08 10:44:00-04:00,HRC,neutral
628320.0,Hill-Rom Holdings Inc Sees FY2013 EPS $2.03-2.09 vs $2.06 Est,2013-05-07 08:53:00-04:00,HRC,neutral
628321.0,Hill-Rom Sees FY13-17 Sales Growth in Low-Single Digits,2013-05-07 08:31:00-04:00,HRC,positive
628322.0,Hill-Rom Receives FDA 510(k) Clearance to Market MetaNeb 4.0 Airway Clearance System,2013-05-06 16:00:00-04:00,HRC,neutral
628323.0,Hill-Rom Holdings Inc Narrows FY2013 EPS Guidance from $2.01-2.11 to $2.03-2.09 vs $2.08 Est,2013-04-24 17:02:00-04:00,HRC,neutral
628324.0,"Hill-Rom Sees Q3 Sales Growth 5-6%, Now Expecting FY Adj. EPS $2.03-2.09",2013-04-24 17:01:00-04:00,HRC,positive
628325.0,Hill-Rom Holdings Inc Reports Q2 EPS of $0.49 vs $0.50 Est; Revenue of $425.70M vs $436.27M Est,2013-04-24 17:00:00-04:00,HRC,neutral
628326.0,CL King Downgrades Hill-Rom Holdings Inc to Sell,2013-02-11 09:39:00-05:00,HRC,neutral
628327.0,"Hilliard Lyons Maintains Long-term Buy on Hill-Rom Holdings Inc, Raises PT to $38.00",2013-01-24 14:28:00-05:00,HRC,neutral
628328.0,Hill-Rom Holdings Inc Sees Q2 EPS $0.48-0.50 vs $0.52 Est,2013-01-23 17:04:00-05:00,HRC,neutral
628329.0,Hill-Rom Holdings Inc Sees FY2013 EPS $2.01-2.11 vs $2.03 Est,2013-01-23 17:02:00-05:00,HRC,neutral
628330.0,Hill-Rom Holdings Inc Reports Q1 EPS of $0.47 vs $0.44 Est; Revenue of $428.0M vs $414.20M Est,2013-01-23 17:02:00-05:00,HRC,neutral
628331.0,Bank of America Downgrades Hill-Rom Holdings Inc to Underperform,2012-12-18 09:35:00-05:00,HRC,neutral
628332.0,UPDATE: Goldman Sachs Upgrades Hill-Rom Holdings to Buy Hospita Bed Market Rebound  ,2012-12-11 11:54:00-05:00,HRC,neutral
628333.0,Goldman Sachs Upgrades Hill-Rom Holdings Inc to Buy,2012-12-11 09:46:00-05:00,HRC,neutral
628334.0,"Hill-Rom Declares Q1 Dividend of $0.125/Share, Payable Dec. 28th to Holders of Record on Dec. 14th",2012-12-03 17:00:00-05:00,HRC,neutral
628335.0,"Bloomberg Sees Disney, Devon Energy, Aetna, Wisconsin Energy, Eastman Chemical, Hill-Rom, Toro Raising Dividends Next Week",2012-11-23 11:01:00-05:00,HRC,positive
628336.0,"Piper Jaffray Maintains Hill-Rom Holdings at Neutral, Raises PT from $30 to $31",2012-10-31 11:12:00-04:00,HRC,neutral
628337.0,Hill-Rom Guides FY13 EPS $2.12-2.22 vs $2.16 Est,2012-10-24 17:47:00-04:00,HRC,neutral
628338.0,Hill-Rom Holdings Reports Q4 EPS $0.56 vs $0.55 Est; Revenues $432M vs $418.07M Est,2012-10-24 17:47:00-04:00,HRC,neutral
628339.0,Hill-Rom Holdings Expands Stock Repurchase by 3.5M Shares,2012-10-03 14:01:00-04:00,HRC,positive
628340.0,"UPDATE: Morgan Stanley Downgrades Hill-Rom Holdings to Equal-Weight, Removes $31 PT",2012-10-03 09:18:00-04:00,HRC,neutral
628341.0,"Morgan Stanley Downgrades Hill-Rom Holdings from Overweight to Equal-weight, Removes PT",2012-10-03 05:52:00-04:00,HRC,negative
628342.0,Hill-Rom Boosts Pact Up to $250M; Provides $500M Revolver and $200 Term Loans,2012-08-24 16:11:00-04:00,HRC,positive
628343.0,UPDATE: Piper Jaffray Downgrades Hill-Rom Holdings to Neutral on Visibility  ,2012-08-02 12:07:00-04:00,HRC,neutral
628344.0,"Piper Jaffray Downgrades Hill-Rom Holdings from Overweight  to Neutral, Lowers PT from $45 to $30",2012-08-02 05:54:00-04:00,HRC,negative
628345.0,"Hilliard Lyons Downgrades Hill-Rom Holdings from Buy to Long-term Buy, Lowers PT from $40 to $35",2012-07-27 12:37:00-04:00,HRC,negative
628346.0,UPDATE: Morgan Stanley Lowers PT on Hill-Rom Holdings from $38 to $31,2012-07-27 10:59:00-04:00,HRC,negative
628347.0,"Morgan Stanley Maintains Hill-Rom Holdings at Overweight, Lowers PT from $38 to $31",2012-07-27 07:36:00-04:00,HRC,negative
628348.0,Hill-Rom Guides Q4 EPS $0.53-0.55 May Not Compare to $0.78 Est; Guides Q4 Revenue $413-421M May Not Compare to $447.41M Est,2012-07-25 17:09:00-04:00,HRC,neutral
628349.0,Hill-Rom Holdings Reports Q3 EPS $0.37 May Not Compare to the $0.57 Est; Revenues $406M May Not Compare to $423.41M Est,2012-07-25 17:07:00-04:00,HRC,neutral
628350.0,UPDATE: Bank of America Upgrades Hill-Rom Holdings to Neutral on Valuation  ,2012-06-13 07:25:00-04:00,HRC,neutral
628351.0,"Bank of America Upgrades Hill-Rom Holdings from Underperform to Neutral, Lowers PO from $34 to $33",2012-06-13 06:27:00-04:00,HRC,negative
628352.0,Hill-Rom Guides FY EPS $2.45-2.50 with Volker vs $2.46 Est; Guides Q3 EPS $0.56-0.58 with Volker vs $0.58 Est,2012-04-25 17:05:00-04:00,HRC,neutral
628353.0,Hill-Rom Holdings Reports Q2 EPS $0.59 vs $0.54 Est; Revenues $415M vs $407.88M Est,2012-04-25 17:02:00-04:00,HRC,neutral
628354.0,Hill-Rom Will Eliminate 3% of Workforce; 200 Jobs,2012-03-26 08:05:00-04:00,HRC,neutral
628355.0,Market Update,2012-03-06 09:53:00-05:00,HRC,neutral
628356.0,Hill-Rom Lifts Quarterly Dividend By 11%,2012-03-06 08:28:00-05:00,HRC,neutral
628357.0,Hill-Rom Increases Second Quarter Dividend by 11% to $0.125  ,2012-03-06 08:06:00-05:00,HRC,neutral
628358.0,"Bank of America Maintains Hill-Rom Holdings at Underperform, Raises PO from $31 to $34",2012-02-24 07:19:00-05:00,HRC,negative
628359.0,Morgan Keegan Says Hill-Rom Holdings May See Increased Competition in Coming Months,2012-01-30 08:34:00-05:00,HRC,positive
628360.0,Morgan Stanley Lowers PT on Hill-Rom Holdings to $38,2012-01-27 06:52:00-05:00,HRC,negative
628361.0,"From Yesterday, Hill-Rom Holdings Reports Q1 EPS $0.53 vs $0.53 Est; Revenues $381.1M vs $384.56M Est	 		",2012-01-26 06:38:00-05:00,HRC,neutral
628362.0,"Bank of America Views Sparrows Point Shutdown as Potentially Positive for AKS, X, STLD, NUE",2011-12-30 10:53:00-05:00,HRC,positive
628363.0,"Morgan Stanley Reiterates Overweight, $38 PT on Hill-Rom Holdings",2011-12-19 09:57:00-05:00,HRC,negative
628364.0,Hill-Rom Announces Definitive Agreement to Acquire Volker for $85M in Cash,2011-12-16 08:00:00-05:00,HRC,positive
628365.0,Bank of America Maintains Buy Rating and $39 PT on Hill-Rom Holdings,2011-10-28 08:56:00-04:00,HRC,neutral
628366.0,UPDATE: Piper Jaffray Raises PT on Hill-Rom Holdings to $46,2011-10-28 07:29:00-04:00,HRC,neutral
628367.0,"Piper Jaffray Raises PT on Hill-Rom Holdings from $44 to $46, Maintains Overweight",2011-10-28 06:17:00-04:00,HRC,negative
628368.0,Hill-Rom Holdings Reports Q4 EPS $0.72 vs $0.70 Est; Revenues $431M vs $420.27M Est		,2011-10-26 17:01:00-04:00,HRC,neutral
628369.0,Piper Jaffray Lowers PT on Hill-Rom Holdings to $44,2011-10-13 07:12:00-04:00,HRC,negative
628370.0,Hill-Rom Statement on U.S. Attorney's Office for the Eastern District of Tennessee Announcement ,2011-09-27 14:15:00-04:00,HRC,neutral
628371.0,Morgan Keegan Overweight On Hill-Rom Holdings,2011-09-15 09:19:00-04:00,HRC,negative
628372.0,Piper Jaffray Reiterating Overweight On Hill-Rom Holdings,2011-09-09 07:43:00-04:00,HRC,negative
628373.0,UPDATE: Bank of America Lowers PT from $48 to $39 on Hill-Rom Holdings,2011-08-04 08:00:00-04:00,HRC,negative
628374.0,Bank of America Lowers PO On Hill-Rom Holdings To $39,2011-08-04 05:55:00-04:00,HRC,negative
628375.0,Goldman Sachs Discusses Hill-Rom Holdings,2011-08-01 15:39:00-04:00,HRC,neutral
628376.0,Morgan Keegan Upgrades Hill-Rom Holdings To Outperform,2011-07-29 08:40:00-04:00,HRC,neutral
628377.0,"News Summary for July 29, 2011",2011-07-29 07:52:00-04:00,HRC,neutral
628378.0,"Morgan Keegan Upgrades Hill-Rom To Outperform, Lowers PT To $45",2011-07-29 06:43:00-04:00,HRC,negative
628379.0,Biggest Losers of the Day,2011-07-28 10:54:00-04:00,HRC,negative
628380.0,Bank of America Comments on Failure of Hill-Rom Holdings to Meet Expectations,2011-07-28 09:07:00-04:00,HRC,negative
628381.0,"Hill-Rom Guides Year EPS $2.26-2.30, Had Seen $2.26-2.32 vs $2.33 Est",2011-07-27 17:03:00-04:00,HRC,neutral
628382.0,Hill Rom Holdings Narrows 2011 EPS Guidance To $2.26-$2.30 vs. $2.33 Est,2011-07-27 17:03:00-04:00,HRC,neutral
628383.0,Hill-Rom Q3 EPS of $0.47 vs. $0.54 Est; Revenues $384.8M vs. $390.47M				,2011-07-27 17:01:00-04:00,HRC,neutral
628384.0,"Morgan Keegan's Favorite Ideas in the Hospital Supplies Group: Baxter, Covidien, and Hill-Rom",2011-07-12 08:49:00-04:00,HRC,positive
628385.0,Kinetic Concepts Causing Peers in Medical Tech Industry to Move Higher,2011-07-06 10:15:00-04:00,HRC,neutral
628386.0,UPDATE: Piper Jaffray Raises PT on Hill-Rom Holdings to $52 ,2011-05-25 08:20:00-04:00,HRC,neutral
628387.0,Deutsche Bank Maintains Hold on Stryker,2011-05-25 07:48:00-04:00,HRC,neutral
628388.0,Piper Jaffray Raises PT on Hill-Rom To $52,2011-05-25 07:31:00-04:00,HRC,neutral
628389.0,Goldman Sachs Introduces FY2015 EPS Estimates On Hill-Rom Holdings,2011-05-19 07:43:00-04:00,HRC,neutral
628390.0,"Goldman Sachs Initiates Hill-Rom Holdings At Neutral, $50 PT",2011-05-17 06:45:00-04:00,HRC,neutral
628391.0,"Hill Rom Expands Stock Repurchase By 3M Shares, Totaling 4.1M Shares (HRC)",2011-05-09 09:09:00-04:00,HRC,positive
628392.0,Hill Rom Raises Dividend to $0.1125 from $0.1025 (HRC),2011-05-09 09:04:00-04:00,HRC,neutral
628393.0,Hill-Rom Reports EPS of $0.52 vs. $0.50 Estimate; Revenues $402.1M vs. $377.5M Estimate (HRC),2011-04-27 17:04:00-04:00,HRC,neutral
628394.0,"Morgan Keegan Leaves Hill-Rom Market Perform, $45 PT Unchanged (HRC)",2011-03-18 08:17:00-04:00,HRC,neutral
628395.0,Morgan Keegan Comments On Hill-Rom Holdings In-line Earnings,2011-01-28 09:20:00-05:00,HRC,neutral
628396.0,HRC Remains Morgan Keegan's Favorite Market Perform-Rated Stock,2011-01-13 08:33:00-05:00,HRC,positive
628397.0,Hill-Rom Enters Oversold Territory - Tale of the Tape,2010-12-27 10:33:00-05:00,HRC,neutral
628398.0,Hill-Rom Enters Oversold Territory - Tale of the Tape,2010-12-27 10:06:00-05:00,HRC,neutral
628399.0,Piper Jaffray Maintains Overweight On Hill-Rom Holdings (HRC),2010-11-30 07:28:00-05:00,HRC,negative
628400.0,"Hill-Rom Appoints Brian Lawrence as VP, Chief Technology Officer",2010-11-29 16:03:00-05:00,HRC,neutral
628401.0,"Hill-Rom Holdings, Inc. - Momentum",2010-11-19 13:00:00-05:00,HRC,neutral
628402.0,"Hill-Rom Holdings, Inc. - Momentum",2010-11-18 19:00:00-05:00,HRC,neutral
628403.0,Morgan Keegan Has Market Perform On Hill-Rom (HRC),2010-11-02 06:59:00-04:00,HRC,neutral
628404.0,Hill-Rom Appoints Mark Guinan as CFO,2010-11-01 09:25:00-04:00,HRC,neutral
628405.0,Bullish MACD for Hill-Rom  - Tale of the Tape,2010-09-09 13:41:00-04:00,HRC,neutral
628406.0,Hill-Rom Announces Fourth Quarter 2010 Dividend,2010-09-07 09:04:00-04:00,HRC,neutral
628407.0,Zacks #1 Rank Additions for Monday  - Tale of the Tape,2010-08-30 08:34:00-04:00,HRC,neutral
628408.0,"Momentum Stock Picks-Aug.19, 2010 - Zacks Rank Buys",2010-08-19 18:52:00-04:00,HRC,neutral
628409.0,"Zacks Releases Four Powerful ''Buy'' Stocks: Textainer Group, Banco de Chile, Hill-Rom Holdings and Fossil - Press Releases",2010-08-17 11:20:00-04:00,HRC,positive
628410.0,"Hill-Rom Holdings, Inc. - Momentum",2010-08-17 02:55:00-04:00,HRC,neutral
628411.0,Morgan Keegan Increases Price Target on Hill-Rom Holdings (HRC),2010-06-21 10:04:00-04:00,HRC,neutral
628412.0,"Benzinga’s Top Downgrades (TSYS, HRC, EME, CMCSA, AIXG)",2010-04-30 10:33:00-04:00,HRC,positive
628413.0,"Morgan Keegan Maintains Market Perform Rating On Hill-Rome Holdings, Inc. (HRC)",2010-04-01 10:21:00-04:00,HRC,neutral
628414.0,"Medical Devices Industry Update (BAX, BCR, COO, MASI, HAE)",2010-03-23 12:33:00-04:00,HRC,neutral
628415.0,New CEO A Positive For Hill-Rom Holdings. Inc (HRC),2010-01-08 11:25:00-05:00,HRC,positive
628416.0,"Hill-Rom Holdings, Inc. (HRC) Appoints John J. Greisch as President and Chief Executive Officer",2010-01-07 11:20:00-05:00,HRC,neutral
628417.0,"Hill-Rom Posts FQ4 results, Getting Attention in Futures Market",2009-11-12 10:15:00-05:00,HRC,neutral
